Caitlin's battle with acute myeloid leukaemia is a stark reminder of the challenges faced by those with rare cancers. At 24, her life was full of promise and potential, with plans to join the Army and train as an intelligence officer. But a rash in March 2025 changed everything. What started as a seemingly minor issue led to a diagnosis that would shape her future.
The initial shock of her diagnosis was followed by a glimmer of hope as she achieved remission after two months of chemotherapy. However, the cancer returned to her skin in August, and her world turned upside down once more. Despite participating in a clinical trial in Manchester using menin inhibitors, which successfully put her into complete remission, the cancer relapsed just a week before her planned stem cell transplant in December 2025.
Caitlin's resilience and determination are remarkable. She underwent the transplant, receiving extra full-body radiotherapy, and was declared in remission once more in January 2026. Yet, the shadow of uncertainty loomed as she faced the possibility of the cancer returning. Her fears were realized in May, when bone marrow monitoring revealed the leukaemia had returned.
The situation is dire, with Caitlin now pursuing curative treatment abroad. The high cost of specialized leukaemia treatment in America or CAR-T cell therapy in China or Singapore presents a significant financial burden. Her family's fundraising efforts to cover these costs are a testament to the emotional and financial toll of such treatments.
Caitlin's story highlights the importance of continued research and support for rare cancers. It also underscores the need for accessible and affordable treatment options, especially for those with limited financial resources. As she battles her illness, Caitlin's courage and resilience serve as an inspiration to all who face similar challenges.
In my opinion, Caitlin's story is a powerful reminder of the human cost of cancer. It highlights the emotional and financial toll of rare cancers and the need for innovative treatments and support systems. It also underscores the importance of continued research and awareness to ensure that those affected by cancer have access to the best possible care and support.
